BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 38169367)

  • 1. Targeting noncoding RNAs to reactivate or eliminate latent HIV reservoirs.
    Beliakova-Bethell N
    Curr Opin HIV AIDS; 2024 Mar; 19(2):47-55. PubMed ID: 38169367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
    Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
    mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Noncoding RNA uc002yug.2 Activates HIV-1 Latency through Regulation of mRNA Levels of Various RUNX1 Isoforms and Increased Tat Expression.
    Huan C; Li Z; Ning S; Wang H; Yu XF; Zhang W
    J Virol; 2018 May; 92(9):. PubMed ID: 29491162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
    Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
    J Virol; 2018 May; 92(9):. PubMed ID: 29444937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Latent HIV-1 T Cell Reservoirs with a Combination of Innate Immune and Epigenetic Regulators.
    Palermo E; Acchioni C; Di Carlo D; Zevini A; Muscolini M; Ferrari M; Castiello L; Virtuoso S; Borsetti A; Antonelli G; Turriziani O; Sgarbanti M; Hiscott J
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31413127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Two-Color Haploid Genetic Screen Identifies Novel Host Factors Involved in HIV-1 Latency.
    Röling M; Mollapour Sisakht M; Ne E; Moulos P; Crespo R; Stoszko M; De Crignis E; Bodmer H; Kan TW; Akbarzadeh M; Harokopos V; Hatzis P; Palstra RJ; Mahmoudi T
    mBio; 2021 Dec; 12(6):e0298021. PubMed ID: 34872356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV.
    Rochat MA; Schlaepfer E; Speck RF
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-Deoxyphorbol inhibits HIV-1 infection in synergism with antiretroviral drugs and reactivates viral reservoirs through PKC/MEK activation synergizing with vorinostat.
    De la Torre-Tarazona HE; Jiménez R; Bueno P; Camarero S; Román L; Fernández-García JL; Beltrán M; Nothias LF; Cachet X; Paolini J; Litaudon M; Alcami J; Bedoya LM
    Biochem Pharmacol; 2020 Jul; 177():113937. PubMed ID: 32224142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of JAK1/2 Inhibitors on HIV Reservoir Using Primary Lymphoid Cell Model of HIV Latency.
    de Armas LR; Gavegnano C; Pallikkuth S; Rinaldi S; Pan L; Battivelli E; Verdin E; Younis RT; Pahwa R; Williams SL; Schinazi RF; Pahwa S
    Front Immunol; 2021; 12():720697. PubMed ID: 34531866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling HIV-1 Latency Using Primary CD4
    Takata H; Kessing C; Sy A; Lima N; Sciumbata J; Mori L; Jones RB; Chomont N; Michael NL; Valente S; Trautmann L
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30918072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cell biology of HIV-1 latency and rebound.
    Mbonye U; Karn J
    Retrovirology; 2024 Apr; 21(1):6. PubMed ID: 38580979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A truncated HIV Tat demonstrates potent and specific latency reversal activity.
    Van Gulck E; Pardons M; Nijs E; Verheyen N; Dockx K; Van Den Eynde C; Battivelli E; Vega J; Florence E; Autran B; Archin NM; Margolis DM; Katlama C; Hamimi C; Van Den Wyngaert I; Eyassu F; Vandekerckhove L; Boden D
    Antimicrob Agents Chemother; 2023 Nov; 67(11):e0041723. PubMed ID: 37874295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep latency: A new insight into a functional HIV cure.
    Elsheikh MM; Tang Y; Li D; Jiang G
    EBioMedicine; 2019 Jul; 45():624-629. PubMed ID: 31227439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternate NF-κB-Independent Signaling Reactivation of Latent HIV-1 Provirus.
    Acchioni C; Remoli AL; Marsili G; Acchioni M; Nardolillo I; Orsatti R; Farcomeni S; Palermo E; Perrotti E; Barreca ML; Sabatini S; Sandini S; Parolin C; Lin R; Borsetti A; Hiscott J; Sgarbanti M
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31243131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated Single-cell Multiomic Analysis of HIV Latency Reversal Reveals Novel Regulators of Viral Reactivation.
    Ashokkumar M; Mei W; Peterson JJ; Harigaya Y; Murdoch DM; Margolis DM; Kornfein C; Oesterling A; Guo Z; Rudin CD; Jiang Y; Browne EP
    Genomics Proteomics Bioinformatics; 2024 May; 22(1):. PubMed ID: 38902848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quiescence Promotes Latent HIV Infection and Resistance to Reactivation from Latency with Histone Deacetylase Inhibitors.
    Painter MM; Zaikos TD; Collins KL
    J Virol; 2017 Dec; 91(24):. PubMed ID: 29021396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic analysis of the unstimulated in vivo HIV CD4 T cell reservoir.
    Neidleman J; Luo X; Frouard J; Xie G; Hsiao F; Ma T; Morcilla V; Lee A; Telwatte S; Thomas R; Tamaki W; Wheeler B; Hoh R; Somsouk M; Vohra P; Milush J; James KS; Archin NM; Hunt PW; Deeks SG; Yukl SA; Palmer S; Greene WC; Roan NR
    Elife; 2020 Sep; 9():. PubMed ID: 32990219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A CRISPR/Cas9 screen identifies the histone demethylase MINA53 as a novel HIV-1 latency-promoting gene (LPG).
    Huang H; Kong W; Jean M; Fiches G; Zhou D; Hayashi T; Que J; Santoso N; Zhu J
    Nucleic Acids Res; 2019 Aug; 47(14):7333-7347. PubMed ID: 31165872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide CRISPR screens identify combinations of candidate latency reversing agents for targeting the latent HIV-1 reservoir.
    Dai W; Wu F; McMyn N; Song B; Walker-Sperling VE; Varriale J; Zhang H; Barouch DH; Siliciano JD; Li W; Siliciano RF
    Sci Transl Med; 2022 Oct; 14(667):eabh3351. PubMed ID: 36260688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal transcriptional response to latency reversing agents identifies specific factors regulating HIV-1 viral transcriptional switch.
    Venkatachari NJ; Zerbato JM; Jain S; Mancini AE; Chattopadhyay A; Sluis-Cremer N; Bar-Joseph Z; Ayyavoo V
    Retrovirology; 2015 Oct; 12():85. PubMed ID: 26438393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.